Related references
Note: Only part of the references are listed.Determinants of the survival benefit associated with statins in patients with acute heart failure
Chan Soon Park et al.
ESC HEART FAILURE (2022)
Heart failure after myocardial infarction: incidence and predictors
Dominik Jenca et al.
ESC HEART FAILURE (2021)
Statins Attenuate Fibrotic Manifestations of Cardiac Tissue Damage
Armita M. Gorabi et al.
CURRENT MOLECULAR PHARMACOLOGY (2021)
Determinants of the survival benefit associated with statins in patients with acute heart failure
Chan Soon Park et al.
ESC HEART FAILURE (2021)
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
Francois Mach et al.
EUROPEAN HEART JOURNAL (2020)
Prior Beta-Blocker Therapy for Hypertension and Sex-Based Differences in Heart Failure Among Patients With Incident Coronary Heart Disease
Raffaele Bugiardini et al.
HYPERTENSION (2020)
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease
Donna K. Arnett et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Statins for the primary prevention of cardiovascular disease: an overview of systematic reviews
Paula Byrne et al.
BMJ OPEN (2019)
Intravenous Statin Administration During Ischemia Exerts Cardioprotective Effects
Guiomar Mendieta et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Sex Differences in Outcomes After STEMI Effect Modification by Treatment Strategy and Age
Edina Cenko et al.
JAMA INTERNAL MEDICINE (2018)
Statins for Primary Prevention The Debate Is Intense, but the Data AreWeak
Rita F. Redberg et al.
JAMA INTERNAL MEDICINE (2017)
Lipids, Statins and Heart Failure: An Update
Niki Katsiki et al.
CURRENT PHARMACEUTICAL DESIGN (2016)
The International Survey of Acute Coronary Syndromes in Transitional Countries (ISACS-TC): 2010-2015
Raffaele Bugiardini et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
Statins for Prevention of Cardiovascular Disease in Adults Evidence Report and Systematic Review for the US Preventive Services Task Force
Roger Chou et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Statin Use for the Primary Prevention of Cardiovascular Disease in Adults US Preventive Services Task Force Recommendation Statement
Kirsten Bibbins-Domingo et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Statins evidence: when answers also raise questions Sharing the data is more likely to settle the debate than another review
Harlan M. Krumholz
BMJ-BRITISH MEDICAL JOURNAL (2016)
Statins evidence: when answers also raise questions Sharing the data is more likely to settle the debate than another review
Harlan M. Krumholz
BMJ-BRITISH MEDICAL JOURNAL (2016)
Unfractionated heparin-clopidogrel combination in ST-elevation myocardial infarction not receiving reperfusion therapy
Raffaele Bugiardini et al.
ATHEROSCLEROSIS (2015)
Myopathy in older people receiving statin therapy: a systematic review and meta-analysis
Roli B. Iwere et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Sex, statins, and statistics
Lori Mosca
LANCET (2015)
Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials
Jordan Fulcher et al.
LANCET (2015)
Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies
Peter C. Austin et al.
STATISTICS IN MEDICINE (2015)
Evaluation of the Methods and Management of Acute Coronary Events (EMMACE)-3: protocol for a longitudinal study
O. A. Alabas et al.
BMJ OPEN (2015)
Heart failure: preventing disease and death worldwide
Piotr Ponikowski et al.
ESC HEART FAILURE (2014)
Statin Therapy in the Prevention of Recurrent Cardiovascular Events
Jose Gutierrez et al.
ARCHIVES OF INTERNAL MEDICINE (2012)
Third Universal Definition of Myocardial Infarction
Kristian Thygesen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
High-dose rosuvastatin in chronic heart failure promotes vasculogenesis, corrects endothelial function, and improves cardiac remodeling - Results from a randomized, double-blind, and placebo-controlled study
Sandra Erbs et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2011)
Statins for the Primary Prevention of Cardiovascular Events in Women With Elevated High-Sensitivity C-Reactive Protein or Dyslipidemia Results From the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and Meta-Analysis of Women From Primary Prevention Trials
Samia Mora et al.
CIRCULATION (2010)
Prevention of heart failure - A scientific statement from the American Heart Association councils on epidemiology and prevention, clinical cardiology, cardiovascular nursing, and high blood pressure research; Quality of care and outcomes research interdisciplinary working group; and functional genomics and translational biology interdisciplinary working group
Douglas D. Schocken et al.
CIRCULATION (2008)
Effect of the magnitude of lipid lowering on risk of elevated liver enzymes, rhabdomyolysis, and cancer - Insights from large randomized statin trials
Alawi A. Alsheikh-Ali et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Statin use and survival in patients with chronic heart failure - results from two observational studies with 5200 patients
Stefan D. Anker et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2006)
Statin and β-blocker therapy and the initial presentation of coronary heart disease
AS Go et al.
ANNALS OF INTERNAL MEDICINE (2006)
Statins in atherosclerosis: Lipid-lowering agents with antioxidant capabilities
RS Rosenson
ATHEROSCLEROSIS (2004)
Dangers of rosuvastatin identified before and after FDA approval
SM Wolfe
LANCET (2004)
Effect of pravastatin on myocardial perfusion after percutaneous transluminal coronary angioplasty
O Manfrini et al.
AMERICAN JOURNAL OF CARDIOLOGY (2004)
Prognostic importance of physical examination for heart failure in non-ST-elevation acute coronary syndromes - The enduring value of Killip classification
UN Khot et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Statistics Notes - Interaction revisited: the difference between two estimates
DG Altman et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Pravastatin for secondary prevention of cardiovascular events in persons with mild chronic renal insufficiency
M Tonelli et al.
ANNALS OF INTERNAL MEDICINE (2003)
Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction - A report from the Second National Registry of Myocardial Infarction (NRMI-2)
AH Wu et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Fluvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, attenuates left ventricular remodeling and failure after experimental myocardial infarction
S Hayashidani et al.
CIRCULATION (2002)
Use of intravascular ultrasound to compare effects of different strategies of lipid-lowering therapy on plaque volume and composition in patients with coronary artery disease
M Schartl et al.
CIRCULATION (2001)
Share Paper
